Two Sigma Investments, LP Concert Pharmaceuticals, Inc. Transaction History

Two Sigma Investments, LP

$42.3 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$4.34 - $5.84 $1.07 Million - $1.44 Million	-247,347 Reduced 67.22%	120,605 $704,000
Q3 2022 Nov 14, 2022	BUY	$4.27 - $7.2 $552,862 - $932,227	129,476 Added 54.29%	367,952 $2.47 Million
Q2 2022 Aug 15, 2022	BUY	$2.8 - $6.36 $634,132 - $1.44 Million	226,476 Added 1887.3%	238,476 $1 Million
Q1 2022 May 16, 2022	SELL	$2.73 - $3.94 $215,397 - $310,866	-78,900 Reduced 86.8%	12,000 $40,000
Q4 2021 Feb 14, 2022	BUY	$2.69 - $4.22 $146,540 - $229,888	54,476 Added 149.56%	90,900 $286,000
Q3 2021 Nov 15, 2021	SELL	$3.17 - $4.15 $27,185 - $35,590	-8,576 Reduced 19.06%	36,424 $119,000
Q2 2021 Aug 16, 2021	SELL	$3.77 - $5.24 $443,340 - $616,208	-117,597 Reduced 72.32%	45,000 $190,000
Q1 2021 May 17, 2021	BUY	$4.86 - $13.07 $650,481 - $1.75 Million	133,844 Added 465.5%	162,597 $811,000
Q4 2020 Feb 16, 2021	SELL	$9.48 - $12.84 $32,601 - $44,156	-3,439 Reduced 10.68%	28,753 $363,000
Q3 2020 Nov 16, 2020	SELL	$8.67 - $10.82 $103,511 - $129,179	-11,939 Reduced 27.05%	32,192 $316,000
Q2 2020 Aug 14, 2020	SELL	$7.8 - $11.52 $79,778 - $117,826	-10,228 Reduced 18.82%	44,131 $439,000
Q1 2020 May 15, 2020	SELL	$5.98 - $13.09 $127,344 - $278,751	-21,295 Reduced 28.15%	54,359 $481,000
Q4 2019 Feb 14, 2020	SELL	$5.71 - $9.22 $267,827 - $432,464	-46,905 Reduced 38.27%	75,654 $698,000
Q3 2019 Nov 14, 2019	BUY	$5.88 - $12.35 $104,681 - $219,867	17,803 Added 16.99%	122,559 $721,000
Q2 2019 Aug 14, 2019	BUY	$9.44 - $13.12 $670,296 - $931,598	71,006 Added 210.39%	104,756 $1.26 Million
Q1 2019 May 15, 2019	SELL	$12.07 - $17.54 $94,013 - $136,619	-7,789 Reduced 18.75%	33,750 $407,000
Q4 2018 Feb 14, 2019	SELL	$11.25 - $16.17 $330,378 - $474,864	-29,367 Reduced 41.42%	41,539 $521,000
Q3 2018 Nov 14, 2018	BUY	$12.82 - $17.88 $363,523 - $507,005	28,356 Added 66.64%	70,906 $1.05 Million
Q2 2018 Aug 14, 2018	BUY	$16.83 - $21.66 $716,116 - $921,633	42,550 New	42,550 $716,000
Q1 2018 May 15, 2018	SELL	$19.24 - $28.03 $2.92 Million - $4.26 Million	-151,875 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$13.96 - $29.05 $2.12 Million - $4.41 Million	151,875	151,875 $3.93 Million

Others Institutions Holding CNCE

# of Institutions

Shares Held

Call Options Held

Put Options Held

Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

View Full List

About CONCERT PHARMACEUTICALS, INC.

Ticker CNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,934,600
Description
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...

More about CNCE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Account